Works by Piha-Paul, Sarina A

Results: 103
    1
    2
    3

    Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study.

    Published in:
    2025
    By:
    • Thein, Kyaw Z.;
    • Karp, Daniel D.;
    • Tsimberidou, Apostolia;
    • Gong, Jing;
    • Sulovic, Selma;
    • Shah, Jatin;
    • Milton, Denái R.;
    • Hong, David S.;
    • Janku, Filip;
    • McQuinn, Lacey;
    • Stephen, Bettzy A.;
    • Colen, Rivka;
    • Carter, Brett W.;
    • Yap, Timothy A.;
    • Piha-Paul, Sarina A.;
    • Fu, Siqing;
    • Meric-Bernstam, Funda;
    • Naing, Aung
    Publication type:
    Correction Notice
    4

    BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study.

    Published in:
    NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-022-00341-0
    By:
    • Nelson, Blessie Elizabeth;
    • Roszik, Jason;
    • Janku, Filip;
    • Hong, David S.;
    • Kato, Shumei;
    • Naing, Aung;
    • Piha-Paul, Sarina;
    • Fu, Siqing;
    • Tsimberidou, Apostolia;
    • Cabanillas, Maria;
    • Busaidy, Naifa Lamki;
    • Javle, Milind;
    • Byers, Lauren Averett;
    • Heymach, John V.;
    • Meric-Bernstam, Funda;
    • Subbiah, Vivek
    Publication type:
    Article
    5

    Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00317-0
    By:
    • Vo, Henry Hiep;
    • Fu, Siqing;
    • Hong, David S.;
    • Karp, Daniel D.;
    • Piha-Paul, Sarina;
    • Subbiah, Vivek;
    • Janku, Filip;
    • Naing, Aung;
    • Yap, Timothy A.;
    • Rodon, Jordi;
    • Ajani, Jaffer A.;
    • Cartwright, Carrie;
    • Johnson, Amber;
    • Song, I-Wen;
    • Beck, Jennifer;
    • Kahle, Michael;
    • Nogueras-Gonzalez, Graciela M.;
    • Miller, Vincent;
    • Chao, Calvin;
    • Vining, David J.
    Publication type:
    Article
    6

    Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00159-2
    By:
    • Tsimberidou, Apostolia Maria;
    • Hong, David S.;
    • Fu, Siqing;
    • Karp, Daniel D.;
    • Piha-Paul, Sarina;
    • Kies, Merrill S.;
    • Ravi, Vinod;
    • Subbiah, Vivek;
    • Patel, Sunil M.;
    • Tu, Shi-Ming;
    • Janku, Filip;
    • Heymach, John;
    • Johnson, Amber;
    • Cartwright, Carrie;
    • Zhao, Li;
    • Zhang, Jianhua;
    • Berry, Donald A.;
    • Vining, David J.;
    • Futreal, Andrew;
    • Miller, Vincent A.
    Publication type:
    Article
    7

    Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
    By:
    • Piha-Paul, Sarina A;
    • Hann, Christine L;
    • French, Christopher A;
    • Cousin, Sophie;
    • Braña, Irene;
    • Cassier, Phillippe A;
    • Moreno, Victor;
    • Bono, Johann S de;
    • Harward, Sara Duckworth;
    • Ferron-Brady, Geraldine;
    • Barbash, Olena;
    • Wyce, Anastasia;
    • Wu, Yuehui;
    • Horner, Thierry;
    • Annan, Meg;
    • Parr, Nigel J;
    • Prinjha, Rabinder K;
    • Carpenter, Christopher L;
    • Hilton, John;
    • Hong, David S
    Publication type:
    Article
    8
    9

    Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial.

    Published in:
    Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00159-1
    By:
    • Subbiah, Vivek;
    • Dumbrava, Ecaterina Ileana;
    • Jiang, Yunfang;
    • Thein, Kyaw Z.;
    • Naing, Aung;
    • Hong, David S.;
    • Fu, Siqing;
    • Piha-Paul, Sarina A.;
    • Tsimberidou, Apostolia M.;
    • Janku, Filip;
    • Meric-Bernstam, Funda;
    • Kurzrock, Razelle;
    • Falchook, Gerald
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Associations between the gut microbiome and fatigue in cancer patients.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84783-9
    By:
    • Hajjar, Joud;
    • Mendoza, Tito;
    • Zhang, Liangliang;
    • Fu, Siqing;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Janku, Filip;
    • Karp, Daniel D.;
    • Ballhausen, Alexej;
    • Gong, Jing;
    • Zarifa, Abdulrazzak;
    • Peterson, Christine B.;
    • Meric-Bernstam, Funda;
    • Jenq, Robert;
    • Naing, Aung
    Publication type:
    Article
    21
    22
    23
    24

    Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 58, doi. 10.1159/000540290
    By:
    • Abou-Alfa, Ghassan K.;
    • Meyer, Tim;
    • Do, Richard Kinh Gian;
    • Piha-Paul, Sarina A.;
    • Light, Joseph S.;
    • Sherrin, Scott;
    • Yaqubie, Amin;
    • O'Neill, Alison Clemens;
    • Harding, James J.;
    • Al-Rajabi, Raed;
    • Denlinger, Crystal S.;
    • Cano, Pablo;
    • Cornelius, Albert S.;
    • O'Reilly, Eileen M.;
    • DiPrimeo, Daniel;
    • Eli, Lisa D.;
    • Gordan, John D.;
    • Solit, David B.
    Publication type:
    Article
    25
    26
    27
    28

    A Decision Support Framework for Genomically Informed Investigational Cancer Therapy.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv098
    By:
    • Meric-Bernstam, Funda;
    • Johnson, Amber;
    • Holla, Vijaykumar;
    • Bailey, Ann Marie;
    • Brusco, Lauren;
    • Chen, Ken;
    • Routbort, Mark;
    • Patel, Keyur P.;
    • Zeng, Jia;
    • Kopetz, Scott;
    • Davies, Michael A.;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Eterovic, Agda Karina;
    • Tsimberidou, Apostolia M.;
    • Broaddus, Russell;
    • Bernstam, Elmer V.;
    • Shaw, Kenna R.;
    • Mendelsohn, John;
    • Mills, Gordon B.
    Publication type:
    Article
    29

    A decision support framework for genomically informed investigational cancer therapy.

    Published in:
    2015
    By:
    • Meric-Bernstam, Funda;
    • Johnson, Amber;
    • Holla, Vijaykumar;
    • Bailey, Ann Marie;
    • Brusco, Lauren;
    • Chen, Ken;
    • Routbort, Mark;
    • Patel, Keyur P;
    • Zeng, Jia;
    • Kopetz, Scott;
    • Davies, Michael A;
    • Piha-Paul, Sarina A;
    • Hong, David S;
    • Eterovic, Agda Karina;
    • Tsimberidou, Apostolia M;
    • Broaddus, Russell;
    • Bernstam, Elmer V;
    • Shaw, Kenna R;
    • Mendelsohn, John;
    • Mills, Gordon B
    Publication type:
    journal article
    30

    SU2C Phase Ib Study of Paclitaxel and MK-2206 in Advanced Solid Tumors and Metastatic Breast Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/dju493
    By:
    • Gonzalez-Angulo, Ana M.;
    • Krop, Ian;
    • Akcakanat, Argun;
    • Huiqin Chen;
    • Shuying Liu;
    • Yisheng Li;
    • Culotta, Kirk S.;
    • Tarco, Emily;
    • Piha-Paul, Sarina;
    • Moulder-Thompson, Stacy;
    • Velez-Bravo, Vivianne;
    • Sahin, Aysegul A.;
    • Doyle, Laurence A.;
    • Kim-Anh Do;
    • Winer, Eric P.;
    • Mills, Gordon B.;
    • Kurzrock, Razelle;
    • Meric-Bernstam, Funda
    Publication type:
    Article
    31
    32

    Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies.

    Published in:
    International Journal of Cancer, 2020, v. 147, n. 8, p. 2190, doi. 10.1002/ijc.33013
    By:
    • Piha‐Paul, Sarina A.;
    • Oh, Do‐Youn;
    • Ueno, Makoto;
    • Malka, David;
    • Chung, Hyun Cheol;
    • Nagrial, Adnan;
    • Kelley, Robin K.;
    • Ros, Willeke;
    • Italiano, Antoine;
    • Nakagawa, Kazuhiko;
    • Rugo, Hope S.;
    • Braud, Filippo;
    • Varga, Andrea Iolanda;
    • Hansen, Aaron;
    • Wang, Hui;
    • Krishnan, Suba;
    • Norwood, Kevin G.;
    • Doi, Toshihiko
    Publication type:
    Article
    33

    Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.

    Published in:
    CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2625, doi. 10.1111/cts.13387
    By:
    • Steeghs, Neeltje;
    • Hansen, Aaron R.;
    • Hanna, Glenn J.;
    • Garralda, Elena;
    • Park, Haeseong;
    • Strauss, James;
    • Adam, Michael;
    • Campbell, Gossett;
    • Carver, Jennifer;
    • Easton, Rachael;
    • Mays, Katherine;
    • Skrdla, Peter;
    • Struemper, Herbert;
    • Washburn, Michael L.;
    • Matheny, Christopher;
    • Piha‐Paul, Sarina A.
    Publication type:
    Article
    34

    Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 14, p. 2201, doi. 10.1002/cncr.34773
    By:
    • Nelson, Blessie Elizabeth;
    • Saleem, Sadia;
    • Damodaran, Senthil;
    • Somaiah, Neeta;
    • Piha‐Paul, Sarina;
    • Moore, Julia Ann;
    • Yilmaz, Bulent;
    • Ogbonna, Deby;
    • Karp, Daniel D.;
    • Dumbrava, Ecaterina;
    • Tsimberidou, Apostolia M.;
    • Hong, David S.;
    • Rodon Ahnert, Jordi;
    • Milton, Denái R.;
    • Zheng, Xiaofeng;
    • Booser, Daniel J.;
    • Ibrahim, Nuhad K.;
    • Conley, Anthony P.;
    • Bhosale, Priya;
    • Rojas Hernandez, Cristhiam M.
    Publication type:
    Article
    35

    Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.

    Published in:
    2022
    By:
    • Ravi, Vinod;
    • Subramaniam, Aparna;
    • Zheng, Jing;
    • Amini, Behrang;
    • Trinh, Van A.;
    • Joseph, Jocelyn;
    • Mennel, Robert G.;
    • Bishop, Andrew J.;
    • Sturgis, Erich M.;
    • Goepfert, Ryan P.;
    • Yalamanchili, Sudha;
    • Botello, Gilberto;
    • Stephen, Bettzy;
    • Piha‐Paul, Sarina A.;
    • Patel, Anisha B.;
    • Lazar, Alexander J.;
    • Conley, Anthony P.;
    • Benjamin, Robert S.;
    • Patel, Shreyaskumar R.;
    • Futreal, Phillip A.
    Publication type:
    journal article
    36
    37

    Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.

    Published in:
    2020
    By:
    • Mehnert, Janice M.;
    • Bergsland, Emily;
    • O'Neil, Bert H.;
    • Santoro, Armando;
    • Schellens, Jan H. M.;
    • Cohen, Roger B.;
    • Doi, Toshihiko;
    • Ott, Patrick A.;
    • Pishvaian, Michael J.;
    • Puzanov, Igor;
    • Aung, Kyaw L.;
    • Hsu, Chiun;
    • Le Tourneau, Christophe;
    • Hollebecque, Antoine;
    • Élez, Elena;
    • Tamura, Kenji;
    • Gould, Marlena;
    • Yang, Ping;
    • Stein, Karen;
    • Piha‐Paul, Sarina A.
    Publication type:
    journal article
    38

    Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.

    Published in:
    2019
    By:
    • Bhatty, Minny;
    • Kato, Shumei;
    • Piha‐Paul, Sarina A.;
    • Naing, Aung;
    • Subbiah, Vivek;
    • Huang, Helen J.;
    • Karp, Daniel D.;
    • Tsimberidou, Apostolia M.;
    • Zinner, Ralph G.;
    • Hwu, Wen‐Jen;
    • Javle, Milind;
    • Patel, Sapna P.;
    • Hu, Mimi I.;
    • Varadhachary, Gauri R.;
    • Conley, Anthony P.;
    • Ramzanali, Nishma M.;
    • Holley, Veronica R.;
    • Kurzrock, Razelle;
    • Meric‐Bernstam, Funda;
    • Kwang Chae, Young
    Publication type:
    journal article
    39
    40

    Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 14, p. 2164, doi. 10.1002/cncr.28701
    By:
    • Hong, David S.;
    • Garrido‐Laguna, Ignacio;
    • Ekmekcioglu, Suhendan;
    • Falchook, Gerald S.;
    • Naing, Aung;
    • Wheler, Jennifer J.;
    • Fu, Siqing;
    • Moulder, Stacy L.;
    • Piha‐Paul, Sarina;
    • Tsimberidou, Apostolia M.;
    • Wen, YueJin;
    • Culotta, Kirk S.;
    • Anderes, Kenna;
    • Davis, Darren W.;
    • Liu, Wen;
    • George, Goldy C.;
    • Camacho, Luis H.;
    • Percy Ivy, Susan;
    • Kurzrock, Razelle
    Publication type:
    Article
    41

    A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 2, p. 107, doi. 10.1007/s00280-023-04545-4
    By:
    • Piha-Paul, Sarina A.;
    • Tseng, Chieh;
    • Tran, Hai T.;
    • Gao, Meng;
    • Karp, Daniel D.;
    • Subbiah, Vivek;
    • Tsimberidou, Apostolia Maria;
    • Kawedia, Jitesh D.;
    • Fu, Siqing;
    • Pant, Shubham;
    • Yap, Timothy A.;
    • Morris, Van K.;
    • Kee, Bryan K.;
    • Blum Murphy, Mariela;
    • Lim, JoAnn;
    • Meric-Bernstam, Funda
    Publication type:
    Article
    42

    Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 825, doi. 10.1007/s00280-021-04329-8
    By:
    • Akce, Mehmet;
    • El-Khoueiry, Anthony;
    • Piha-Paul, Sarina A.;
    • Bacque, Emeline;
    • Pan, Peng;
    • Zhang, Zhi-Yi;
    • Ewesuedo, Reginald;
    • Gupta, Divya;
    • Tang, Yongqiang;
    • Milton, Ashley;
    • Zajic, Stefan;
    • Judson, Patricia L.;
    • O'Bryant, Cindy L.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit.

    Published in:
    Oncology, 2017, v. 92, n. 1, p. 14, doi. 10.1159/000449505
    By:
    • Kinahan, Holly;
    • Maiti, abhishek;
    • Hess, Kenneth;
    • Dempsey, Jennifer;
    • Beatty, Laura;
    • Baldwin, Sarah;
    • Hong, David S.;
    • Naing, aung;
    • Fu, Siqing;
    • Tsimberidou, apostolia M.;
    • Piha-Paul, Sarina;
    • Janku, Filip;
    • Karp, Daniel;
    • Reddy, Suresh;
    • Yennu, Sriram;
    • Epner, Daniel;
    • Bruera, Eduardo;
    • Meric-Bernstam, Funda;
    • Falchook, Gerald;
    • Subbiah, Vivek
    Publication type:
    Article
    50

    Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.

    Published in:
    Oncology, 2016, v. 91, n. 6, p. 348, doi. 10.1159/000449204
    By:
    • Subbiah, Vivek;
    • Holmes, Oliver;
    • Gowen, Kyle;
    • Spritz, Daniel;
    • amini, Behrang;
    • Wang, Wei-Lien;
    • Schrock, alexa B.;
    • Meric-Bernstam, Funda;
    • Zinner, Ralph;
    • Piha-Paul, Sarina;
    • Zarzour, Maria;
    • Elvin, Julia a.;
    • Erlich, Rachel L.;
    • Stockman, David L.;
    • Vergilio, Jo-anne;
    • Suh, James H.;
    • Stephens, Philip J.;
    • Miller, Vincent;
    • Ross, Jeffrey S.;
    • ali, Siraj M.
    Publication type:
    Article